Document:

Exhibit
10.69

 

PROMISSORY
NOTE

 

	U.S.
    $242,000.00	January
    3, 2017

 

FOR
VALUE RECEIVED, BioRestorative Therapies, Inc., a Delaware corporation (“Borrower”), promises to pay in lawful
money of the United States of America to the order of St. George Investments LLC, a Utah limited liability company, or its successors
or assigns (“Lender”), the principal sum of $242,000.00, together with all other amounts due under this Promissory
Note (this “Note”). This Note is issued pursuant to that certain Note Purchase Agreement of even date herewith
between Borrower and Lender (the “Purchase Agreement”).

 

1.
PAYMENT. Borrower shall pay to Lender the entire outstanding balance of this Note on or before the date that is six (6)
months from the date hereof (the “Maturity Date”). Borrower will make all payments of sums due hereunder to
Lender at Lender’s address set forth in the Purchase Agreement, or at such other place as Lender may designate in writing.
Unless otherwise agreed or required by applicable law, payments will be applied first to any unpaid collection costs and late
charges, then to accrued interest and finally to principal.

 

2.
INTEREST. Interest shall not accrue on the unpaid principal balance of this Note unless an Event of Default (as defined
below) occurs. Upon the occurrence of an Event of Default, the outstanding balance of this Note shall bear interest at the lesser
of the rate of eighteen percent (18%) per annum or the maximum rate permitted by applicable law, compounding daily and calculated
on the basis of a 360-day year, from the date due until paid.

 

3.
ORIGINAL ISSUE DISCOUNT; TRANSACTION EXPENSES. This Note carries an original issue discount of $40,000.00. In addition,
Borrower agrees to pay $2,000.00 to Lender to cover Lender’s legal fees, accounting costs, due diligence, monitoring and
other transaction costs incurred in connection with the purchase and sale of this Note, all of which amounts are included in the
initial principal balance of this Note and are fully earned and payable as of the date hereof (subject only to the prepayment
discount set forth in Section 4 below).

 

4.
PREPAYMENT. Borrower may pay without penalty all or a portion of the amount owed earlier than it is due. Early payments
of less than all principal, fees and interest outstanding will not, unless agreed to by Lender in writing, relieve Borrower of
any of Borrower’s obligations hereunder. Should Borrower make any prepayment in accordance with the schedule set forth below,
the amount payable shall be the amount set forth below under the heading “Prepayment Amount,” and upon Lender’s
receipt of such amount, this Note shall be deemed paid in full notwithstanding the fact that such payment may be less than the
initial outstanding balance of this Note:

 

	Prepayment
    Deadline	 	Prepayment
    Amount
	 	 	 
	Borrower
        pays the entire outstanding balance of this Note on or before the date that is ninety (90) days from the date this Note
        is issued

        
	 	$222,000.00
    (which reflects a $20,000.00 discount to the original outstanding balance)
	 	 	 
	Borrower
pays the entire outstanding balance of this Note after the date that is ninety (90) days from the date this Note is issued but
on or before the date that is one hundred thirty-five (135) days from the date this Note is issued 
	 	$232,000.00
    (which reflects a $10,000.00 discount to the original outstanding balance)

 

    	 	 	 

    	 

    

 

5.
EVENT OF DEFAULT. The occurrence and continuance of any of the following shall constitute an “Event of Default”
under this Note:

 

(a)
Failure to Pay. Borrower shall fail to pay when due, whether at stated maturity, upon acceleration or otherwise, any principal
or interest payment, or any other payment required under the terms of this Note on the date due.

 

(b)
Breaches of Covenants. Borrower fails to comply in any material respect with or to perform when due any other term, obligation,
covenant, or condition contained in this Note, in the Purchase Agreement, any other Transaction Document (as defined in the Purchase
Agreement), and such failure continues unremedied for a period of thirty (30) days following receipt of written notice thereof
from Lender.

 

(c)
Representations and Warranties. Any representation or warranty made by Borrower to Lender in this Note, the Purchase Agreement,
any other Transaction Document, or any related agreement shall be false, incorrect, incomplete or misleading in any material respect
when made or furnished.

 

(d)
Voluntary Bankruptcy or Insolvency Proceedings. Borrower shall (i) apply for or consent to the appointment of a receiver,
trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) make a general assignment for
the benefit of its or any of its creditors, (iii) be dissolved or liquidated, or (iv) commence a voluntary case or other proceeding
seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other
similar law now or hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property
by any official in an involuntary case or other proceeding commenced against it.

 

(e)
Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver, trustee, liquidator, or
custodian of Borrower or of all or a substantial part of its property, or an involuntary case or other proceedings seeking liquidation,
reorganization, or other relief with respect to Borrower or its debts under any bankruptcy, insolvency or other similar law now
or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be dismissed or discharged
within sixty (60) days of commencement.

 

(f)
Judgment. A judgment or judgments for the payment of money in excess of the sum of $200,000.00 in the aggregate shall be
rendered against Borrower and either (i) the judgment creditor executes on such judgment or (ii) such judgment remains unpaid
or undischarged for more than sixty (60) days from the date of entry thereof or such longer period during which execution of such
judgment shall be stayed during an appeal from such judgment.

 

(g)
Attachment. Any execution or attachment shall be issued whereby any substantial part of the property of Borrower shall
be taken and the same shall not have been vacated or stayed within thirty (30) days after the issuance thereof.

 

    	 	2	 

    	 

    

 

(h)
Cross Default. Borrower breaches or any event of default occurs under any term or provision of any Other Agreement (as
defined hereafter) and such breach or event of default remains uncured for a period of thirty (30) days following receipt of written
notice thereof from Lender. For purposes hereof, “Other Agreement” means collectively, (i) all existing and
future agreements and instruments between, among or by Borrower (or an affiliate), on the one hand, and Lender (or an affiliate),
on the other hand, and (ii) any material financing agreement or a material agreement that affects Borrower’s ongoing business
operations.

 

6.
ACCELERATION; REMEDIES.

 

(a)
At any time following the occurrence of an Event of Default (other than an Event of Default referred to in Sections 5(d) and
5(e)), Lender may, by written notice to Borrower, declare all unpaid principal, plus all accrued interest and other amounts
due hereunder to be immediately due and payable at the Mandatory Default Amount (as defined below) without presentment, demand,
protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding.
Upon the occurrence or existence of any Event of Default described in Sections 5(d) and 5(e), immediately and without notice,
all outstanding unpaid principal, plus all accrued interest and other amounts due hereunder shall automatically become immediately
due and payable at the Mandatory Default Amount, without presentment, demand, protest or any other notice of any kind, all of
which are hereby expressly waived, anything contained herein to the contrary notwithstanding. In addition to the foregoing remedies,
upon the occurrence or existence of any Event of Default, Lender may exercise any other right, power or remedy permitted to it
by law, either by suit in equity or by action at law, or both. For purposes hereof, the term “Mandatory Default Amount”
means an amount equal to 110% of the outstanding balance of this Note as of the date the applicable Event of Default occurred,
plus all interest, fees, and charges that may accrue on such outstanding balance thereafter.

 

(b)
Upon the occurrence of a Change in Control (as defined below), and without further notice to Borrower, all unpaid principal, plus
all accrued interest and other amounts due hereunder, shall become immediately due and payable. For purposes hereof, a “Change
in Control” means a sale of all or substantially all of Borrower’s assets, or a merger, consolidation, or other
capital reorganization of Borrower with or into another company; provided however that a merger, consolidation,
or other capital reorganization in which the holders of the equity of Borrower outstanding immediately prior to such transaction
continue to hold (either by the voting securities remaining outstanding or by being converted into voting securities of the surviving
entity) more than fifty percent (50%) of the total voting power represented by the voting securities of Borrower, or such surviving
entity, outstanding immediately after such transaction shall not constitute a Change in Control.

 

7.
UNCONDITIONAL OBLIGATION; NO OFFSET. Borrower acknowledges that this Note is an unconditional, valid, binding and enforceable
obligation of Borrower not subject to offset, deduction or counterclaim of any kind. Borrower hereby waives any rights of offset
it now has or may have hereafter against Lender, its successors and assigns, and agrees to make all payments due hereunder in
accordance with the terms of this Note.

 

    	 	3	 

    	 

    

 

8.
NO USURY. Notwithstanding any other provision contained in this Note or in any instrument given to evidence the obligations
evidenced hereby: (a) the rates of interest and charges provided for herein and therein shall in no event exceed the rates and
charges which result in interest being charged at a rate equaling the maximum allowed by law; and (b) if, for any reason whatsoever,
Lender ever receives as interest in connection with the transaction of which this Note is a part an amount which would result
in interest being charged at a rate exceeding the maximum allowed by law, such amount or portion thereof as would otherwise be
excessive interest shall automatically be applied toward reduction of the unpaid principal balance then outstanding hereunder
and not toward payment of interest.

 

9.
ATTORNEYS’ FEES. If this Note is placed in the hands of an attorney for collection or enforcement prior to commencing
arbitration or legal proceedings, or is collected or enforced through any arbitration or legal proceeding, or Lender otherwise
takes action to collect amounts due under this Note or to enforce the provisions of this Note, then Borrower shall pay the costs
incurred by Lender for such collection, enforcement or action including, without limitation, reasonable attorneys’ fees
and disbursements.

 

10.
GOVERNING LAW; VENUE. This Note shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Note shall be governed by, the internal laws of the State of Utah, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of Utah or any other jurisdictions) that
would cause the application of the laws of any jurisdictions other than the State of Utah. The provisions set forth in the Purchase
Agreement to determine the proper venue for any disputes are incorporated herein by this reference.

 

11.
ARBITRATION OF DISPUTES. Borrower agrees that any dispute arising under this Note shall be subject to the Arbitration Provisions
(as defined in the Purchase Agreement) set forth as an exhibit to the Purchase Agreement.

 

12.
WAIVERS. Borrower hereby waives presentment, notice of nonpayment, notice of dishonor, protest, demand and diligence.

 

13.
LOSS OR MUTILATION. On receipt by Borrower of evidence reasonably satisfactory to Borrower of the loss, theft, destruction
or mutilation of this Note and, in the case of any such loss, theft or destruction of this Note, on delivery of an indemnity agreement
reasonably satisfactory in form and amount to Borrower or, in the case of any such mutilation, on surrender and cancellation of
such Note, Borrower at its expense will execute and deliver, in lieu thereof, a new Note of like tenor.

 

14.
NOTICES. Any notice required or permitted hereunder shall be given in the manner provided in the subsection titled “Notices”
in the Purchase Agreement, the terms of which are incorporated herein by this reference.

 

15.
AMENDMENT AND WAIVER. This Note and its terms and conditions may be amended, waived or modified only in writing by Borrower
and Lender.

 

16.
SEVERABILITY. If any part of this Note is construed to be in violation of any law, such part shall be modified to achieve
the objective of the parties to the fullest extent permitted and the balance of this Note shall remain in full force and effect.

 

    	 	4	 

    	 

    

 

17.
ASSIGNMENTS. Borrower may not assign this Note without the prior written consent of Lender. This Note may be offered, sold,
assigned or transferred by Lender without the consent of Borrower.

 

18.
FINAL NOTE. This Note, together with the other Transaction Documents, contains the complete understanding and agreement
of Borrower and Lender and supersedes all prior representations, warranties, agreements, arrangements, understandings, and negotiations.
THIS NOTE, TOGETHER WITH THE OTHER TRANSACTION DOCUMENTS, REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED
BY EVIDENCE OF ANY ALLEGED PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS
BETWEEN THE PARTIES.

 

19.
Waiver of Jury Trial. BORROWER IRREVOCABLY WAIVES ANY AND ALL RIGHTS IT
MAY HAVE TO DEMAND THAT ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS NOTE OR THE RELATIONSHIPS
OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING UNDER COMMON
LAW OR ANY APPLICABLE STATUTE, LAW, RULE OR REGULATION. FURTHER, BORROWER ACKNOWLEDGES THAT IT KNOWINGLY AND VOLUNTARILY IS WAIVING
SUCH PARTY’S RIGHT TO DEMAND TRIAL BY JURY.

 

20.
TIME IS OF THE ESSENCE. Time is of the essence of this Note and each and every provision hereof in which time is an element.

 

21.
LIQUIDATED DAMAGES. Lender and Borrower agree that in the event Borrower fails to comply with any of the terms or provisions
of this Note, Lender’s damages would be uncertain and difficult (if not impossible) to accurately estimate because of the
parties’ inability to predict future interest rates and other relevant factors. Accordingly, Lender and Borrower agree that
any fees, balance adjustments, default interest or other charges assessed under this Note are not penalties but instead are intended
by the parties to be, and shall be deemed, liquidated damages.

 

[Remainder
of page intentionally left blank]

 

    	 	5	 

    	 

    

 

IN
WITNESS WHEREOF, Borrower has caused this Note to be issued as of the date first set forth above.

 

	 	BORROWER:
	 	 
	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:
    	                                      
	 	 	Mark
    Weinreb, President

 

[Signature
Page to Promissory Note]

 

    	 	6Exhibit
10.70

 

VOID
AFTER 5:00 P.M., EASTERN TIME, ON MARCH 1, 2022

 

NEITHER
THIS WARRANT NOR THE WARRANT STOCK (AS HEREINAFTER DEFINED) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE. THIS WARRANT AND THE WARRANT STOCK MAY BE TRANSFERRED ONLY IN COMPLIANCE
WITH THE ACT AND SUCH LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY WARRANT ISSUED IN EXCHANGE FOR THIS WARRANT.

 

 

 

BIORESTORATIVE
THERAPIES, INC.

 

(Incorporated
under the laws of the State of Delaware)

 

Warrant

 

	______
    Shares	March
1, 2017

 

FOR
VALUE RECEIVED, BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), hereby certifies that
__________________ (the “Holder”) is entitled, subject to the provisions of this Warrant, to purchase from
the Company up to _____________________ (________) SHARES OF COMMON STOCK, $.001 par value per share, of the Company (“Common
Shares”) at a price of FOUR DOLLARS ($4.00) per share (the “Exercise Price”) during the period commencing
on the date hereof and terminating at 5:00 P.M. on the fifth anniversary of the date hereof.

 

The
number of Common Shares to be received upon the exercise of this Warrant may be adjusted from time to time as hereinafter set
forth. The Common Shares deliverable upon such exercise, and as adjusted from time to time, are hereinafter sometimes referred
to as “Warrant Stock.”

 

The
Holder agrees with the Company that this Warrant is issued, and all the rights hereunder shall be held subject to, all of the
conditions, limitations and provisions set forth herein.

 

1.
Exercise of Warrant. This Warrant may be exercised by its presentation and surrender to the Company at 40 Marcus
Drive, Suite One, Melville, New York 11747 (or such office or agency of the Company as it may designate in writing to the Holder
hereof) with the Warrant Exercise Form attached hereto duly executed and accompanied by payment (either in cash or by official
bank check, payable to the order of the Company) of the Exercise Price for the number of shares specified in such Form. The Company
agrees that the Holder hereof shall be deemed the record owner of such Common Shares as of the close of business on the date on
which this Warrant shall have been presented and payment made for such Common Shares as aforesaid whether or not the Company or
its transfer agent is open for business. Certificates for the Common Shares so purchased shall be delivered to the Holder hereof
within a reasonable time after the rights represented by this Warrant shall have been so exercised. If this Warrant is exercised
in part only, the Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing
the rights of the Holder hereof to purchase the balance of the shares purchasable hereunder.

 

    	 

    	 

    

 

2.
Registered Owner. The Company may consider and treat the person in whose name this Warrant shall be registered as
the absolute owner thereof for all purposes whatsoever and the Company shall not be affected by any notice to the contrary. Subject
to the provisions hereof, the registered owner of this Warrant shall have the right to transfer it by assignment and the transferee
thereof, upon his registration as owner of this Warrant, shall become vested with all the powers and rights of the transferor.
Registration of any new owner shall take place upon presentation of this Warrant to the Company at its offices together with the
Warrant Assignment Form attached hereto duly executed. In case of transfers by operation of law, the transferee shall notify the
Company of such transfer and of his address, and shall submit appropriate evidence regarding the transfer so that this Warrant
may be registered in the name of the transferee. This Warrant is transferable only on the books of the Company by the Holder on
the surrender hereof, duly endorsed. Communications sent to any registered owner shall be effective as against all holders or
transferees of this Warrant not registered at the time of sending the communication.

 

3.
Reservation of Shares. During the period within which the rights represented by this Warrant may be exercised, the
Company shall, at all times, reserve and keep available out of its authorized capital stock, solely for the purposes of issuance
upon exercise of this Warrant, such number of its Common Shares as shall be issuable upon the exercise of this Warrant; and if
at any time the number of authorized Common Shares shall not be sufficient to effect the exercise of this Warrant, the Company
will take such corporate action as may be necessary to increase its authorized but unissued Common Shares to such number of shares
as shall be sufficient for such purpose; the Company shall have analogous obligations with respect to any other securities or
property issuable upon exercise of this Warrant.

 

4.
Fractional Shares. The Company shall not be required to issue certificates representing fractions of Common Shares,
nor shall it be required to issue scrip or pay cash in lieu of fractional interests, it being the intent of the Company and the
Holder that all fractional interests shall be eliminated.

 

5.
Rights of the Holder. The Holder shall not, by virtue hereof, be entitled to any voting or other rights of a stockholder
of the Company, either at law or in equity, and the rights of the Holder are limited to those expressed in this Warrant.

 

6.
Anti-Dilution Provisions.

 

6.1
Adjustments for Stock Dividends; Combinations, Etc. (a) In case the Company shall do any of the following (an “Event”):

 

(i)
declare a dividend or other distribution on its Common Shares payable in Common Shares of the Company,

 

(ii)
subdivide the outstanding Common Shares pursuant to a stock split or otherwise,

 

(iii)
combine the outstanding Common Shares into a smaller number of shares pursuant to a reverse split or otherwise, or

 

    	2

    	 

    

 

(iv)
reclassify its Common Shares,

 

then
the Exercise Price in effect at the time of the record date for such dividend or other distribution or of the effective date of
such subdivision, combination or reclassification shall be changed to a price determined by dividing (a) the product of the number
of Common Shares outstanding immediately prior to such Event, multiplied by the Exercise Price in effect immediately prior to
such Event by (b) the number of Common Shares outstanding immediately after such Event. Each such adjustment of the Exercise Price
shall be calculated to the nearest one-hundredth of a cent. Such adjustment shall be made successively whenever any Event listed
above shall occur.

 

(b)
Whenever the Exercise Price is adjusted as set forth in Section 6.1 (whether or not the Company then or thereafter elects to issue
additional Warrants in substitution for an adjustment in the number of shares of Warrant Stock), the number of shares of Warrant
Stock specified in each Warrant which the Holder may purchase shall be adjusted, to the nearest full share, by multiplying such
number of shares of Warrant Stock immediately prior to such adjustment by a fraction, of which the numerator shall be the Exercise
Price immediately prior to such adjustment and the denominator shall be the Exercise Price immediately thereafter.

 

6.2
Adjustment for Reorganization, Consolidation or Merger. In case of any reorganization of the Company (or any other
entity, the securities of which are at the time receivable on the exercise of this Warrant) after the date hereof or in case after
such date the Company (or any such other entity) shall consolidate with or merge with or into another entity, then, and in each
such case, the Holder of this Warrant upon the exercise thereof as provided in Section l at any time after the consummation of
such reorganization, consolidation or merger, shall be entitled to receive, in lieu of the securities and property receivable
upon the exercise of this Warrant prior to such consummation, the securities or property to which such Holder would have been
entitled upon such consummation if such Holder had exercised this Warrant immediately prior thereto, all subject to further adjustment
as provided in Section 6.l; in each such case, the terms of this Warrant shall be applicable to the securities or property receivable
upon the exercise of this Warrant after such consummation.

 

7.
Investment Intent. Unless, prior to the exercise of this Warrant, the issuance of the Warrant Stock has been registered
with the Securities and Exchange Commission pursuant to the Act, the Warrant Exercise Form shall be accompanied by the Investment
Representation Letter attached hereto, duly executed by the Holder.

 

8.
Restrictions on Transfer.

 

8.1
Transfer to Comply with the Securities Act of 1933. Neither this Warrant nor any Warrant Stock may be sold, assigned,
transferred or otherwise disposed of except as follows: (1) to a person who, in the opinion of counsel satisfactory to the Company,
is a person to whom this Warrant or the Warrant Stock may legally be transferred without registration and without the delivery
of a current prospectus under the Act with respect thereto and then only against receipt of an agreement of such person to comply
with the provisions of this Section 8 with respect to any resale, assignment, transfer or other disposition of such securities;
or (2) to any person upon delivery of a prospectus then meeting the requirements of the Act relating to such securities and the
offering thereof for such sale, assignment, transfer or disposition.

 

    	3

    	 

    

 

8.2
Legend. Subject to the terms hereof, upon exercise of this Warrant and the issuance of the Warrant Stock, all certificates
representing such Warrant Stock shall bear on the face or reverse thereof substantially the following legend:

 

“The
securities which are represented by this certificate have not been registered under the Securities Act of 1933, and may not be
sold, transferred, hypothecated or otherwise disposed of until a registration statement with respect thereto is declared effective
under such act, or the Company receives an opinion of counsel for the Company that an exemption from the registration requirements
of such act is available.”

 

9.
Lost, Stolen or Destroyed Warrant. In the event that the Holder notifies the Company that this Warrant has been
lost, stolen or destroyed and provides (a) a letter, in form satisfactory to the Company, to the effect that it will indemnify
the Company from any loss incurred by it in connection therewith, and/or (b) an indemnity bond in such amount as is reasonably
required by the Company, the Company having the option of electing either (a) or (b) or both, the Company may, in its sole discretion,
accept such letter and/or indemnity bond in lieu of the surrender of this Warrant as required by Section 1 hereof.

 

10.
Notices. All notices required hereunder shall be given by first-class mail, postage prepaid, or overnight mail or
courier and, if given by the Holder addressed to the Company at 40 Marcus Drive, Suite One, Melville, New York 11747, Attention:
Chief Executive Officer, or such other address as the Company may designate in writing to the Holder; and if given by the Company,
addressed to the Holder at the address of the Holder shown on the books of the Company.

 

11.
Applicable Law; Jurisdiction. This Warrant is issued under, and shall for all purposes be governed by and construed
in accordance with, the laws of the State of Delaware, excluding choice of law principles thereof. The Company and, by its acceptance
of this Warrant, the Holder hereby irrevocably consent and submit to the exclusive jurisdiction of any federal or state court
located within Nassau or Suffolk County, New York over any dispute arising out of or relating to this Warrant and each party hereby
irrevocably agrees that all claims in respect of such dispute or any legal action related thereto may be heard and determined
in such courts. Each of the Company and the Holder hereby irrevocably waives, to the fullest extent permitted by applicable law,
any objection that it or he may now or hereafter have to the laying of venue of any such dispute brought in such court or any
defense of inconvenient forum for the maintenance of such dispute.

 

[Remainder
of Page Intentionally Left Blank; Signature Page Follows]

 

    	4

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed on its behalf, in its corporate name, by its duly authorized
officer, all as of the day and year first above written.

 

	 	BIORESTORATIVE
    THERAPIES, INC.
	 	 	 
	 	By:	                        
	 	 	Mark
    Weinreb
	 	 	Chief
    Executive Officer

 

    	 

    	 	 	 

    

 

BIORESTORATIVE
THERAPIES, INC.

 

WARRANT
EXERCISE FORM

 

The
undersigned hereby irrevocably elects to exercise the within Warrant dated as of March 1, 2017 to the extent of purchasing ______________
shares of Common Stock of BIORESTORATIVE THERAPIES, INC. The undersigned hereby makes a payment of $__________ in payment
therefor.

 

	TO
    BE COMPLETED BY INDIVIDUAL	 	TO
    BE COMPLETED BY CORPORATE,
	HOLDER,
    JOINT TENANTS, TENANTS	 	PARTNERSHIP,
    LIMITED LIABILITY
	IN
    COMMON OR AS HOLDERS OF	 	COMPANY
    OR TRUST HOLDER
	COMMUNITY
    PROPERTY	 	 
	 	 	 
	 	 	 
	Name(s)
    of Holder(s) [Please Print]	 	Name
    of Holder [Please Print]
	 	 	 
	 	 	By:	                     
	Signature
    of Holder	 	Authorized
    Signatory
	 	 	 
	 	 	 
	Signature
    of Holder, if jointly held	 	Name
    and Title of Authorized Signatory
	 	 	[Please
    Print]
	 	 	 
	 	 	 
	Address(es)
    of Holder(s)	 	Address
    of Holder
	 	 	 
	 	 	 
	Social
    Security Number(s) of Holder(s)	 	Tax
    Identification Number of Holder
	 	 	 
	 	 	 
	Date	 	Date

 

    	 

    	 	 	 

    

 

BIORESTORATIVE
THERAPIES, INC.

 

WARRANT
ASSIGNMENT FORM

 

FOR
VALUE RECEIVED, ___________________________________ hereby sells, assigns and transfers unto _________________________________________ (please type
or print name of assignee) with an address at ______________________________________________________________ the right to purchase
shares of Common Stock of BIORESTORATIVE THERAPIES, INC. (the “Company”) represented by this Warrant dated
as of March 1, 2017 to the extent of ___________ shares and does hereby irrevocably constitute and appoint ___________________
attorney to transfer the same on the books of the Company with full power of substitution in the premises.

 

	TO
    BE COMPLETED BY INDIVIDUAL	 	TO
    BE COMPLETED BY CORPORATE,
	HOLDER,
    JOINT TENANTS, TENANTS	 	PARTNERSHIP,
    LIMITED LIABILITY
	IN
    COMMON OR AS HOLDERS OF 	 	COMPANY
    OR TRUST HOLDER
	COMMUNITY
    PROPERTY	 	 
	 	 	 
	 	 	 
	Name(s)
    of Holder(s) [Please Print]	 	Name
    of Holder [Please Print]
	 	 	 
	 	 	By:	                     
	Signature
    of Holder	 	Authorized
    Signatory
	 	 	 
	 	 	 
	Signature
    of Holder, if jointly held	 	Name
    and Title of Authorized Signatory
	 	 	[Please
    Print]
	 	 	 
	 	 	 
	Date	 	Date

 

Signature(s)
Guaranteed:

 

    	 

    	 	 	 

    

 

BIORESTORATIVE
THERAPIES, INC.

 

FORM
OF INVESTMENT REPRESENTATION LETTER

 

BioRestorative
Therapies, Inc.

40
Marcus Drive

Suite
One

Melville,
New York 11747

 

Gentlemen:

 

In
connection with the acquisition of _______________ shares of Common Stock (the “Shares”) of BIORESTORATIVE THERAPIES,
INC., a Delaware corporation (the “Company”), by the undersigned from the Company pursuant to the exercise of
a Warrant, dated as of March 1, 2017, the undersigned does hereby represent and warrant to the Company as follows:

 

	 	(a)	The
    undersigned represents and warrants that the Shares acquired by it are being acquired for its own account, for investment
    purposes and not with a view to any distribution within the meaning of the Securities Act of 1933, as amended (the “Securities
    Act”). The undersigned will not sell, assign, mortgage, pledge, hypothecate, transfer or otherwise dispose of any of
    the Shares unless (i) a registration statement under the Securities Act with respect thereto is in effect and the prospectus
    included therein meets the requirements of Section 10 of the Securities Act, or (ii) the Company has received a written opinion
    of its counsel that, after an investigation of the relevant facts, such counsel is of the opinion that such proposed sale,
    assignment, mortgage, pledge, hypothecation, transfer or disposition does not require registration under the Securities Act
    or any state securities law.
	 	 	 
	 	(b)	The
    undersigned understands that the resale of the Shares is not, and is not being, registered under the Securities Act and the
    Shares must be held indefinitely unless they are subsequently registered thereunder or an exemption from such registration
    is available. 
	 	 	 
	 	(c)	The
    undersigned recognizes that the acquisition of the Shares involves a high degree of risk and is suitable only for persons
    of adequate financial means who have no need for liquidity with respect to the Shares in that (a) it may not be able to liquidate
    the Shares in the event of emergency; (b) transferability is extremely limited; and (c) it could sustain a complete loss of
    its investment.
	 	 	 
	 	(d)	The
    undersigned represents and warrants that it (a) is competent to understand and does understand the nature of its investment;
    and (b) is able to bear the economic risk of an acquisition of the Shares.

 

    	 

    	 	 	 

    

 

	 	(e)	The
    undersigned represents and warrants that it is an “accredited investor,” as such term is defined in Rule 501 of
    Regulation D promulgated under the Securities Act. The undersigned meets the requirements of at least one of the suitability
    standards for an “accredited investor” as set forth on the Accredited Investor Certification attached hereto.
    
	 	 	 
	 	(f)	The
    undersigned has reviewed the Company’s filings with the Securities and Exchange Commission, including the risk factors
    set forth therein, and has been afforded the opportunity to obtain such information regarding the Company as it has reasonably
    requested to evaluate the merits and risks of the undersigned’s investment in the Shares. No oral or written representations
    have been made or oral information furnished to the undersigned or its advisers in connection with the investment in the Shares.
	 	 	 
	 	(g)	The
    undersigned confirms that the representations and warranties set forth in the Subscription Agreement pursuant to which the
    Warrant was issued are true and correct as of the date hereof as if made on and as of the date hereof with respect to the
    purchase of the Shares.
	 	 	 
	 	(h)	The
    undersigned acknowledges that counsel to the Company will be relying, and may rely, upon the foregoing in connection with
    any opinion of counsel it may give with regard to the issuance of the Shares by the Company to the undersigned, and any subsequent
    transfer of the Shares by the undersigned, and agrees to advise the Company and its counsel in writing in the event of any
    change in any of the foregoing.

 

	 	 	Very
    truly yours,
	 	 	 
	TO
    BE COMPLETED BY INDIVIDUAL	 	TO
    BE COMPLETED BY CORPORATE,
	HOLDER,
    JOINT TENANTS, TENANTS	 	PARTNERSHIP,
    LIMITED LIABILITY
	IN
    COMMON OR AS HOLDERS OF 	 	COMPANY
    OR TRUST HOLDER
	COMMUNITY
    PROPERTY	 	 
	 	 	 
	 	 	 
	Name(s)
    of Holder(s) [Please Print]	 	Name
    of Holder [Please Print]
	 	 	 
	 	 	By:	                      
	Signature
    of Holder	 	Authorized
    Signatory
	 	 	 
	 	 	 
	Signature
    of Holder, if jointly held	 	Name
    and Title of Authorized Signatory
	 	 	[Please
    Print]
	 	 	 
	 	 	 
	Date	 	Date

 

    	 

    	 	 	 

    

 

BIORESTORATIVE
THERAPIES, INC.

 

WARRANT
EXERCISE

 

Accredited
Investor Certification

 

(Initial
the appropriate box(es))

 

 The undersigned represents and warrants that it, he or she is an “accredited investor” based upon the satisfaction of one or more of the following criteria:

 

	_____	(1)
    he or she is a natural person who has a net worth or joint net worth with his or her spouse in excess of $1,000,000 at the
    time of his or her purchase1; or 
	 	 
	_____	(2)
    he or she is a natural person who had an individual income in excess of $200,000 in each of the two most recent years or a
    joint income with his or her spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching
    the same income level in the current year; or 
	 	 
	_____	(3)
    he or she is a director or executive officer of the Company; or 
	 	 
	_____	(4)
    it is either (a) a bank as defined in Section 3(a)(2) of the Securities Act or a savings and loan association or other institution
    as defined in Section 3(a)(5)(A) of the Securities Act, whether acting in its individual or fiduciary capacity, (b) a broker
    or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, (c) an insurance company as defined in
    Section 2(13) of the Securities Act, (d) an investment company registered under the Investment Company Act of 1940 or a business
    development company as defined in Section 2(a)(48) of such act, (e) a small business investment company licensed by the United
    States Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, (f) a plan
    established and maintained by a state or its political subdivisions, or any agency or instrumentality of a state or its political
    subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000 or (g) an employee benefit
    plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment decision is made
    by a plan fiduciary, as defined in Section 3(21) of such act, which plan fiduciary is a bank, savings and loan association,
    an insurance company or a registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000
    or, if a self-directed plan, with investment decisions made solely by persons who otherwise meet these suitability standards;
    or 

 

 

1For purposes of calculating net
worth:

(i)
The undersigned’s primary residence shall not be included as an asset; 

(ii)
Indebtedness that is secured by the undersigned’s primary residence, up to the estimated fair market value of the primary
residence at the date hereof, shall not be included as a liability (except that if the amount of such indebtedness outstanding
at the date hereof exceeds the amount outstanding 60 days before the date hereof, other than as a result of the acquisition of
the primary residence, the amount of such excess shall be included as a liability); and

(iii)
Indebtedness that is secured by the undersigned’s
primary residence in excess of the estimated fair market value of the primary residence at the date hereof shall be included as
a liability.

 

    	 

    	 	 	 

    

 

	_____	(5)
    it is a private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940; or 
	 	 
	_____	(6)
    it is an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, a corporation, a Massachusetts
    or similar business trust or a partnership not formed for the specific purpose of acquiring the Shares offered hereby, with
    total assets in excess of $5,000,000; or 
	 	 
	_____	(7)
    it is a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares, whose
    purchase is directed by a sophisticated person who has such knowledge and experience in financial and business matters that
    he or she is capable of evaluating the merits and risks of the prospective investment; or 
	 	 
	_____	(8)
    it is a corporation, partnership or other entity, and each and every equity owner of such entity initials a separate Accredited
    Investor Certification pursuant to which it, he or she certifies that it, he or she meets the qualifications set forth in
    either (1), (2), (3), (4), (5), (6) or (7) above.

 

	If
    the Warrant Holder is an INDIVIDUAL,	 	If
    the Warrant Holder is a PARTNERSHIP,
	or
    if the Shares are being acquired as JOINT	 	CORPORATION,
    LIMITED LIABILITY
	TENANTS,
    as TENANTS IN COMMON, or as	 	COMPANY
    or TRUST:
	COMMUNITY
    PROPERTY:	 	 
	 	 	 
	 	 	 
	Name(s)
    of Warrant Holder	 	Name
    of Warrant Holder
	 	 	 
	 	 	By:	                    
	Signature
    of Warrant Holder	 	Signature
    of Authorized Representative
	 	 	 
	 	 	 
	Signature,
    if jointly held	 	Name
    and Title of Authorized Representative
	 	 	 
	 	 	 
	Date	 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]